MAM
Kearney reshuffles Asia-Pacific leadership as firm marks centenary year
SINGAPORE: Global management consultancy Kearney has rolled out a fresh leadership line-up across Asia Pacific, signalling a renewed push on growth and client impact as the firm enters its 100th year.
Sarovar Agarwal has been appointed managing partner for Australia and New Zealand, succeeding Adam Dixon, who moves into the role of chairman for the region. Agarwal brings over two decades of experience advising telecom and media clients across India and the Asia-Pacific on transformation and productivity.
In Japan, Takefumi Harigaya takes over as managing director from Shigeru Sekinada, who will continue as Asia-Pacific region chair and assume the role of chairman for Japan. Harigaya has more than 20 years of experience in business transformation and mergers and acquisitions.
Kearney has also named Keat Yap as country head for Malaysia, while Marco de la Rosa becomes Asia-Pacific leader for the firm’s communications, media and technology practice.
Separately, Adam Dixon and Makoto Inoue have been elected to Kearney’s global board, underscoring the region’s rising influence within the firm’s global strategy.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
